Thursday, April 25, 2013

MDL Precedent Rescue - Big List


Several of us (the Reed Smith side, obviously) recently attended the firm partners’ retreat.  All our brainstorming about how to improve client service started us thinking about the blog.  In some ways, legal blogging’s not that much different than other legal services – we just don’t get paid for it, at least not directly.  Our intended readership follows us, to the extent they do, with the expectation (realistic, we hope) of learning things that they can use to help defeat drug/device product liability litigation.  That brings value to the industry (and indirectly to various clients), since a win anywhere helps defendants everywhere.

So where can we bring, or at least preserve, value to the industry/our clients through the blog?  We thought about MDLs.  Defendants spend a great deal of money slogging their way through MDLs, and where possible we’d like to preserve whatever good we get out of them.  Depending on judicial predilection (Judge Bechtle didn’t; Judge Weinstein does), MDLs often include summary judgment and (less frequently) other dispositive motions concerning individuals or groups of plaintiffs.  Some of the motions are based on Daubert, but if not, they’re usually based on state law – learned intermediary, statute of limitations, other issues.

So what?

Here’s what.  State-law-based rulings in MDLs involve judges in one jurisdiction, like Judge Weinstein in New York in Zyprexa, deciding issues presented by other states’ laws – say whether a failure to warn was causal under Louisiana law.  That’s fine for the MDL, but what about the rest of us?  Also, what about anybody after an MDL is (at long last) concluded?  What legal researcher would think to look in New York for a case possibly presenting a relevant fact pattern for a Louisiana motion?

Not too many.

We speak from experience.  When we’re putting together a summary judgment motion in some other case, whether one-off or a different MDL, where do we look for supportive precedent?  Why we look in the logical place, of course – the decisions of that particular state’s courts and federal decisions in the district and appellate courts responsible for that state.  That’s where we get the most bang for our research bucks.  That’s doing our clients’ work in the most efficient manner.

So we don’t look in Florida, or New York, or Pennsylvania if we’re working on a case under Texas law.  It’s simply not cost effective, given the number of other jurisdictions and the relatively low likelihood of success.  Sometimes we run across something significant through checking lists of citations (colloquially known as “Shepardizing”) to relevant cases, but we’re not systematic.

But just because it’s not worthwhile in a given case to conduct such broader searches doesn’t mean that what’s out there isn’t worth knowing about.  In Zyprexa alone, Judge Weinstein granted dozens of summary judgments applying the law of at least half the states of the union.  Those cases are useful precedent – if defense counsel can locate them in a way that doesn’t waste the client’s money.

That’s where we come in.  We’re bloggers.  We’re not getting paid for this.  We don’t have to be cost effective in the narrow sense that lawyers working for client X or client Y have to be.  We just have to do the research – and we have.

What follows will be incredibly boring to many of you, but we hope equally useful.  We’ve collected individual summary judgment decisions (unless we specify a different procedural posture) in various MDLs – no matter what jurisdiction they were in.  We’ve organized them by state, omitting decisions made by MDL courts applying their own forum’s law, since those cases would be found by searching “the usual suspects.”  That means, if you’re researching Mississippi law, just look under “Mississippi law cases” in the list below, and there are the cases, no matter what MDL court decided them.

Caveat #1:  As we’ve said many times, we don’t do the other side’s research for them.  These lists include only cases where the defendant won everything (or almost everything) under a particular state’s law.  As far as adverse MDL precedent is concerned, we make no representations whatsoever.  Yeah, we saw some bad cases while doing this research.  We’ve intentionally omitted them.

Caveat #2.  We expect this list is underinclusive.  Why?  To keep the searches manageable, we reviewed only cases where “product liability” appeared in the name of the case (the usual way that MDLs are named), and “[insert state name] law” appeared somewhere in the body of the opinion.  That means we searched “Alabama law,” not just “Alabama.”  Otherwise, we’d have gotten hits for every MDL case where one of the (often scores) of attorneys was from Alabama.  Still, we think our results are a lot better than nothing.  We’re not aware of this kind of list having been compiled anywhere – at least anywhere that’s public.

Caveat #3.  We’ve only included issues that we could see possibly arising in drug and device product liability litigation.  If an MDL decision was favorable to the defendant only on, say, asbestos exposure product identification (the most common example by far), we have not included it.

Caveat #4. We have not included decisions that were driven by federal issues, such as Daubert or preemption.  Federal issues involve different research considerations, so that decisions from MDLs in different circuits are less useful.

So here goes.  For the first time anywhere, pro-defense product liability MDL decisions organized by the jurisdiction of the law being applied.

Alabama law cases
  • Cooper v. Bristol-Myers Squibb Co., 2013 WL 85291 (D.N.J. Jan. 7, 2013) adequacy, warnings about risks not encountered by plaintiff, warning causation under the learned intermediary rule, design defect, manufacturing defect, negligence
  • In re Yasmin and Yaz Marketing, Sales Practices & Products Liability Litigation, 2012 WL 1831789 (S.D. Ill. May 18, 2012) (motion to amend) – pharmacy liability, express and implied warranties
  • In Re Yasmin and Yaz Marketing, Sales Practices & Products Liability Litigation, 870 F. Supp.2d 587 (S.D. Ill. 2012) (fraudulent joinder) − pharmacy liability, express and implied warranties
  • In re Zyprexa Products Liability Litigation, 2011 WL 3162698 (E.D.N.Y. July 26, 2011) statute of limitations
  • In re Trasylol Products Liability Litigation, 2011 WL 2117257 (S.D. Fla. May 23, 2011) warning causation under the learned intermediary rule; express and implied warranty; fraud
  • In re Trasylol Products Liability Litigation, 2010 WL 5140439 (S.D. Fla. Feb. 16, 2010) wrongful death; statute of limitations; express and implied warranty, fraudulent concealment
  • In re Bextra & Celebrex Marketing Sales Practices & Product Liability Litigation, 495 F. Supp.2d 1027 (N.D. Cal. 2007) (motion to dismiss) − consumer fraud; standing
  • In re Diet Drugs Products Liability Litigation, 2003 WL 21973329 (E.D. Pa. June 12, 2003) (motion to remand) − sales representatives
  • In re Rezulin Products Liability Litigation, 168 F. Supp.2d 136 (S.D.N.Y. 2001) (motion to remand) − sales representatives
  • In re Rezulin Products Liability Litigation, 133 F. Supp.2d 272 (S.D.N.Y. 2001) (motion to remand) − sales representatives
  • In re TMJ Implants Products Liability Litigation, 872 F. Supp. 1019 (D. Minn. 1995), aff’d, 97 F.3d 1050 (8th Cir. 1996) sophisticated user; bulk purchaser

Alaska law cases
  • None

Arizona law cases
  • In re Whirlpool Corp. Front-Loading Washer Products Liability Litigation, 684 F. Supp.2d 942 (N.D. Ohio 2009) warranty; privity
  • In re Zyprexa Products Liability Litigation, 649 F. Supp.2d 18 (E.D.N.Y. 2009), aff’d, 394 Fed. Appx. 819 (2d Cir. 2010) warning causation under the learned intermediary rule
  • In re Zyprexa Products Liability Litigation, 2009 WL 5062109 (E.D.N.Y. Dec. 10, 2009), aff’d, 394 Fed. Appx. 817 (2d Cir. Oct. 4, 2010) warning causation under the learned intermediary rule; statute of limitations

Arkansas law cases
  • In re Zyprexa Products Liability Litigation, 2011 WL 4963048 (E.D.N.Y. Oct. 18, 2011) warning causation under the learned intermediary rule
  • In re Zyprexa Products Liability Litigation, 653 F. Supp.2d 181 (E.D.N.Y. 2009) warning causation under the learned intermediary rule
  • In re Ford Motor Co. E-350 Van Products Liability Litigation (No. II), 2008 WL 4126264 (D.N.J. Sept. 2, 2008) (motion to dismiss) – consumer fraud injury requirement; warranty; notice

California law cases
  • Mattson v. Bristol-Myers Squibb Co., 2013 WL 1758647 (D.N.J. April 24, 2013) warning causation under the learned intermediary rule, manufacturing defect, negligence
  • In re Vioxx Products Liability Litigation, 861 F. Supp.2d 756 (E.D. La. 2012) unjust enrichment
  • In re Zyprexa Products Liability Litigation, 2012 WL 1392993 (E.D.N.Y. April 23, 2012) statute of limitations
  • In re Diet Drugs Products Liability Litigation, 2012 WL 1172164 (E.D. Pa. April 9, 2012) (judgment on the pleadings)  − consumer fraud
  • In re Trasylol Products Liability Litigation, 2010 WL 6098571 (S.D. Fla. March 16, 2010) statute of limitations
  • In re Whirlpool Corp. Front-Loading Washer Products Liability Litigation, 684 F. Supp.2d 942 (N.D. Ohio 2009) warranty; privity
  • In re Ford Motor Co. Speed Control Deactivation Switch Products Liability Litigation, 664 F. Supp.2d 752 (E.D. Mich. 2009) (motion to dismiss) − consumer fraud; unjust enrichment
  • In re Zyprexa Products Liability Litigation, 2009 WL 5062114 (E.D.N.Y. Dec. 10, 2009), aff’d, 394 Fed. Appx. 814 (2d Cir. 2010) statute of limitations
  • In re Zyprexa Products Liability Litigation, 2009 WL 3596982 (E.D.N.Y. Oct. 20, 2009) warning causation under the learned intermediary rule
  • In re Zyprexa Products Liability Litigation, 2009 WL 3597447 (E.D.N.Y. Oct. 16, 2009), aff’d, 394 Fed. Appx. 821 (2d Cir. 2010) statute of limitations
  • In re Zyprexa Products Liability Litigation, 2009 WL 8705812 (E.D.N.Y. Aug. 6, 2009) statute of limitations
  • In re Zyprexa Products Liability Litigation, 2009 WL 2485829 (E.D.N.Y. July 31, 2009) statute of limitations
  • In re Zyprexa Products Liability Litigation, 2009 WL 1851999 (E.D.N.Y. June 24, 2009), aff’d, 394 Fed. Appx. 825 (2d Cir. 2010) warning causation under the learned intermediary rule
  • In re Zyprexa Products Liability Litigation, 2009 WL 1852001 (E.D.N.Y. June 22, 2009), aff’d, 394 Fed. Appx. 823 (2d Cir. 2010) warning causation under the learned intermediary rule
  • In re Zyprexa Products Liability Litigation, 2009 WL 1850970 (E.D.N.Y. June 22, 2009) warning causation under the learned intermediary rule; statute of limitations
  • In re Vioxx Products Liability Litigation, 2007 WL 3334339 (E.D. La. Nov. 8, 2007) statute of limitations, cross-jurisdictional class action tolling
  • In re Bridgestone/Firestone, Inc., Tires Products Liability Litigation, 287 F. Supp. 2d 929 (S.D. Ind. 2003) statute of limitations

Colorado law cases
  • In re Trasylol Products Liability Litigation, 2013 WL 1192300 (S.D. Fla. March 22, 2013) warranty statute of limitations

Connecticut law cases
  • In re Darvocet, Darvon & Propoxyphene Products Liability Litigation, 2012 WL 3610237 (E.D. Ky. Aug. 21, 2012) product identification; misrepresentation; Conte
  • In re Aredia & Zometa Products Liability Litigation, 2012 WL 2015791 (M.D. Tenn. June 5, 2012) suit filed by dead person
  • In re Bridgestone/Firestone, Inc. Tires Products Liability Litigation, 314 F. Supp.2d 818 (S.D. Ind. 2004) statute of limitations

Delaware law cases
  • None

Florida law cases
  • In re Fosamax Products Liability Litigation, 707 F.3d 189 (2d Cir. 2013) warning causation under the learned intermediary rule
  • In re Fosamax Products Liability Litigation, ___ Fed. Appx. ___, 2013 WL 335987 (2d Cir. Jan. 30, 2013) compliance presumption; design defect
  • Scelta v. Boehringer Ingelheim Pharmaceuticals, Inc., 404 Fed. Appx. 92 (8th Cir. 2010) warning causation under the learned intermediary rule, consumer fraud, misrepresentation, reliance
  • LaBarre v. Bristol-Myers Squibb Co., 2013 WL 144054 (D.N.J. Jan. 11, 2013) adequacy as a matter of law, warnings about risks not encountered by plaintiff, efficacy as opposed to risk, warning causation under the learned intermediary rule, design defect, manufacturing defect, negligence
  • In re Darvocet, Darvon & Propoxyphene Products Liability Litigation, 2012 WL 3842045 (E.D. Ky. Sept. 5, 2012) product identification; misrepresentation; Conte
  • In re Zimmer NexGen Knee Implant Products Liability Litigation, 890 F. Supp.2d 896 (N.D. Ill. 2012) (discovery motion) − informal interview with treating physician
  • In re Fosamax Products Liability Litigation, 807 F. Supp.2d 168 (S.D.N.Y. 2011) warning causation under the learned intermediary rule; punitive damages; fraudulent misrepresentation
  • In re Avandia Marketing, Sales Practices & Products Liability Litigation, 2011 WL 4059952 (E.D. Pa. Sept. 7, 2011) (motion to dismiss) – consumer fraud; medical monitoring; unjust enrichment
  • In re Whirlpool Corp. Front-Loading Washer Products Liability Litigation, 684 F. Supp.2d 942 (N.D. Ohio 2009) warranty; privity
  • Hall v. Bristol-Myers Squibb Co., 2009 WL 5206144 (D.N.J. Dec. 30, 2009) consumer fraud, physician reliance, misrepresentation, physician reliance
  • In re Zyprexa Products Liability Litigation, 2009 WL 2004540 (E.D.N.Y. July 1, 2009), aff’d, 387 Fed. Appx. 28 (2d Cir. 2010) warning causation under the learned intermediary rule
  • In re Rezulin Products Liability Litigation, 2006 WL 695253 (S.D.N.Y. March 15, 2006) cross-jurisdictional class action tolling
  • In re Phenylpropanolamine (PPA) Products Liability Litigation, 2005 WL 2090675 (W.D. Wash. Aug. 29, 2005) (motion to dismiss) − duty to test
  • In re Phenylpropanolamine (PPA) Products Liability Litigation, 2005 WL 2207037 (W.D. Wash. Aug. 29, 2005) (motion to dismiss) − duty to test
  • In re Diet Drugs Products Liability Litigation, 2004 WL 1925010 (E.D. Pa. Aug. 30, 2004) (motion to remand) – pharmacy liability
  • In re Diet Drugs Products Liability Litigation, 2004 WL 1824357 (E.D. Pa. Aug. 12, 2004) (motion to remand) – sales representatives; pharmacy liability
  • In re Rezulin Products Liability Litigation, 2004 WL 1109914 (S.D.N.Y. May 18, 2004) implied warranty; privity
  • In re Rezulin Products Liability Litigation, 2002 WL 737501 (S.D.N.Y. April 26, 2002) (motion to remand) – sales representatives
  • In re Rezulin Products Liability Litigation, 2002 WL 511550 (S.D.N.Y. April 4, 2002) (motion to remand) – pharmacy liability
  • In re TMJ Implants Products Liability Litigation, 872 F. Supp. 1019 (D. Minn. 1995), aff’d, 97 F.3d 1050 (8th Cir. 1996) sophisticated user; bulk purchaser
  • In re Ford Motor Co. Bronco II Products Liability Litiagtion, 1995 WL 714441, (E.D. La. Dec. 4, 1995) (motion to dismiss) − fraud
  • Sager v. Hoffman-La Roche, Inc., 2012 WL 3166630 (N.J. Super. App. Div. Aug. 7, 2012) (unreported) warning causation under the learned intermediary rule

Georgia law cases
  • In re Porsche Cars North America, Inc., 880 F. Supp.2d 801 (S.D. Ohio 2012) implied warranty, consumer protection, unjust enrichment
  • In re Darvocet, Darvon & Propoxyphene Products Liability Litigation, 856 F. Supp.2d 904 (E.D. Ky. 2012) (motion to dismiss) − product identification; misrepresentation; Conte
  • In re Ford Motor Co. Speed Control Deactivation Switch Products Liability Litigation, 664 F. Supp.2d 752 (E.D. Mich. 2009) (motion to dismiss) – economic loss rule
  • In re Diet Drugs Products Liability Litigation, 294 F. Supp.2d 667 (E.D. Pa. 2003) (motion to remand) – lobbyist; misrepresentation
  • In re TMJ Implants Products Liability Litigation, 872 F. Supp. 1019 (D. Minn. 1995), aff’d, 97 F.3d 1050 (8th Cir. 1996) sophisticated user; bulk purchaser

Hawaii law cases
  • None

Idaho law cases
  • In re Cessna 208 Series Aircraft Products Liability Litigation, 591 F. Supp.2d 1161 (D. Kan. 2008) economic loss rule
  • In re Cessna 208 Series Aircraft Products Liability Litigation, 2006 WL 3858465 (D. Kan. Dec. 22, 2006) (motion to amend) − fraud

Illinois law cases
  • Begley v. Bristol-Myers Squibb Co., 2013 WL 144177 (D.N.J. Jan. 11, 2013) adequacy as a matter of law, warnings about risks not encountered by plaintiff, efficacy as opposed to risk, expert testimony requirement, design defect, manufacturing defect, negligence
  • In re Darvocet, Darvon & Propoxyphene Products Liability Litigation, 2012 WL 1332437 (E.D. Ky. March 29, 2012) product identification; misrepresentation; Conte
  • In re Bextra & Celebrex Marketing Sales Practices & Product Liability Litigation, 2012 WL 3154957 (N.D. Cal. Aug. 2, 2012) (motion to dismiss) – consumer fraud; fraud; reliance; unjust enrichment
  • In re Vioxx Products Liability Litigation, 2012 WL 2021945 (E.D. La. June 5, 2012), reconsideration denied, 2012 WL 3158842 (E.D. La. Aug. 2, 2012) statute of limitations
  • In re Avandia Marketing, Sales Practices & Products Liability Litigation, 2011 WL 4007858 (E.D. Pa. Sept. 7, 2011) (motion to dismiss) fraudulent misrepresentation; consumer fraud; unjust enrichment
  • In re Trasylol Products Liability Litigation, 2010 WL 8354662 (S.D. Fla. Nov. 23, 2010) fraud; reliance
  • In re Ford Motor Co. E-350 Van Products Liability Litigation (No. II), 2010 WL 2813788 (D.N.J. July 9, 2010) consumer fraud; statute of limitations; unjust enrichment
  • In re Zyprexa Products Liability Litigation, 2010 WL 331793 (E.D.N.Y. Jan. 28, 2010) statute of limitations)
  • In re Zyprexa Products Liability Litigation, 2010 WL 348276 (E.D.N.Y. Jan. 22, 2010) warning causation under the learned intermediary rule
  • In re Ford Motor Co. Speed Control Deactivation Switch Products Liability Litigation, 664 F. Supp.2d 752 (E.D. Mich. 2009) (motion to dismiss) – economic loss rule
  • In re Zyprexa Products Liability Litigation, 2009 WL 3597194 (E.D.N.Y. Oct. 16, 2009) warning causation under the learned intermediary rule
  • In re Vioxx Products Liability Litigation, 522 F. Supp.2d 799 (E.D. La. 2007) statute of limitations; cross-jurisdictional class action tolling
  • In re Cessna 208 Series Aircraft Products Liability Litigation, 2006 WL 3858465 (D. Kan. Dec. 22, 2006) (motion to amend) − fraud
  • In re TMJ Implants Products Liability Litigation, 872 F. Supp. 1019 (D. Minn. 1995), aff’d, 97 F.3d 1050 (8th Cir. 1996) sophisticated user; bulk purchaser

Indiana law cases
  • In re Mentor Corp. ObTape Transobturator Sling Products Liability Litigation, 2013 WL 592409 (M.D. Ga. Feb. 14, 2013) warranty; statute of limitations
  • In re Darvocet, Darvon & Propoxyphene Products Liability Litigation, 856 F. Supp.2d 904 (E.D. Ky. 2012) (motion to dismiss) − product identification; misrepresentation; Conte
  • In re Vioxx Products Liability Litigation, 2007 WL 3334339 (E.D. La. Nov. 8, 2007) statute of limitations, cross-jurisdictional class action tolling
  • In re Rezulin Products Liability Litigation, 2005 WL 383704 (S.D.N.Y. Feb. 16, 2005) wrongful death; appointment of personal representative

Iowa law cases
  • None

Kansas law cases
  • In re MI Windows & Doors, Inc. Products Liability Litigation, 2013 WL 1442332 (D.S.C. April 9, 2013) (motion to dismiss) – fraudulent concealment; express warranty
  • In re Digitek Products Liability Litigation, 2010 WL 2102330 (S.D.W. Va. May 25, 2010) consumer fraud; warranty; extraterritoriality
  • In re Zyprexa Products Liability Litigation, 2010 WL 1292268 (E.D.N.Y. March 30, 2010) statute of limitations
  • In re Diet Drugs Products Liability Litigation, 2000 WL 1886594 (E.D. Pa. Dec. 7, 2000) (motion to remand) – pharmacy liability
  • In re TMJ Implants Products Liability Litigation, 872 F. Supp. 1019 (D. Minn. 1995), aff’d, 97 F.3d 1050 (8th Cir. 1996) sophisticated user; bulk purchaser

Kentucky law cases
  • In re ConAgra Peanut Butter Products Liability Litigation, 2012 WL 3779088 (N.D. Ga. Aug. 29, 2012) (motion to dismiss) – warranty; privity; public nuisance; negligence per se
  • In re Avandia Marketing, Sales Practices & Products Liability Litigation, 2012 WL 3205620 (E.D. Pa. Aug. 7, 2012) statute of limitations
  • In re Digitek Products Liability Litigation, 2010 WL 2102330 (S.D.W. Va. May 25, 2010) warranty; extraterritoriality
  • In re Bextra & Celebrex Marketing Sales Practices & Product Liability Litigation, 244 F.R.D. 558 (N.D. Cal. 2007) substitution of personal representative
  • In re Vioxx Products Liability Litigation, 2007 WL 3353404 (E.D. La. Nov. 8, 2007) cross-jurisdictional class action tolling
  • In re Diet Drugs Products Liability Litigation, 352 F. Supp.2d 533 (E.D. Pa. 2004) statute of limitations
  • In re Bridgestone/Firestone Inc. ATX ATX II & Wilderness Tires Products Liability Litigation, 2002 WL 31689271 (S.D. Ind. Nov. 20, 2002) statute of limitations; fraudulent concealment

Louisiana law cases
  • In re Darvocet, Darvon & Propoxyphene Products Liability Litigation, 856 F. Supp.2d 904 (E.D. Ky. 2012) (motion to dismiss) − product identification; misrepresentation; Conte
  • In re Ford Motor Co. Speed Control Deactivation Switch Products Liability Litigation, 664 F. Supp.2d 752 (E.D. Mich. 2009) (motion to dismiss) − unjust enrichment
  • In re Zyprexa Products Liability Litigation 2009 WL 3596526 (E.D.N.Y. Oct. 16, 2009) warning causation under the learned intermediary rule
  • In re Rezulin Products Liability Litigation, 524 F. Supp.2d 436 (S.D.N.Y. 2007) fraud on the market
  • In re Phenylpropanolamine (PPA) Products Liability Litigation, 2007 WL 505424 (W.D. Wash. Feb. 9, 2007) statute of limitations
  • In re Rezulin Products Liability Litigation, 392 F. Supp.2d 597 (S.D.N.Y. 2005) consumer fraud; standing
  • In re Phenylpropanolamine (PPA) Products Liability Litigation, 2005 WL 1287814 (W.D. Wash. May 31, 2007) statute of limitations
  • In re Rezulin Products Liability Litigation, 361 F. Supp.2d 268 (S.D.N.Y. 2005) compensable injury; fraud; redhibition
  • In re Diet Drugs Products Liability Litigation, 2004 WL 1925010 (E.D. Pa. Aug. 30, 2004) (motion to remand) – pharmacy liability
  • In re Rezulin Products Liability Litigation, 2002 WL 398763 (S.D.N.Y. March 14, 2002) (motion to dismiss) − pharmacy liability
  • In re Rezulin Products Liability Litigation, 133 F. Supp.2d 272 (S.D.N.Y. 2001) (motion to remand) − pharmacy liability
  • In re TMJ Implants Products Liability Litigation, 872 F. Supp. 1019 (D. Minn. 1995), aff’d, 97 F.3d 1050 (8th Cir. 1996) sophisticated user; bulk purchaser

Maine law cases
  • None

Maryland law cases
  • In re Zyprexa Products Liability Litigation, 2012 WL 2374644 (E.D.N.Y. June 22, 2012) warning causation under the learned intermediary rule

Massachusetts law cases
  • In re Ford Motor Co. E-350 Van Products Liability Litigation (No. II), 2010 WL 2813788 (D.N.J. July 9, 2010) cognizable injury; express warranty; puffery; unjust enrichment
  • In re Norplant Contraceptive Products Liability Litigation, 215 F. Supp.2d 795 (E.D. Tex. 2002) learned intermediary rule

Michigan law cases
  • In re MI Windows and Doors, Inc. Products Liability Litigation, 2012 WL 5182416 (D.S.C. Oct. 18, 2012) (motion to dismiss) − economic loss rule
  • In re Porsche Cars North America, Inc. Plastic Coolant Tubes Products Liability Litigation, 880 F. Supp.2d 801 (S.D. Ohio 2012) (motion to dismiss) − economic loss rule
  • In re Zyprexa Products Liability Litigation, 2009 WL 2163118 (E.D.N.Y. July 13, 2009), aff’d, 394 Fed. Appx. 827 (2d Cir. 2010) warning causation under the learned intermediary rule
  • In re Prempro Products Liability Litigation, 2008 WL 1699211 (E.D. Ark. April 9, 2008) drug immunity statute
  • In re Bridgestone/Firestone, Inc. Tires Products Liability Litigation, 2001 WL 34136027 (S.D. Ind. Sept. 14, 2001) warranty; cognizable injury

Minnesota law cases
  • In re Darvocet, Darvon & Propoxyphene Products Liability Litigation, 856 F. Supp.2d 904 (E.D. Ky. 2012) (motion to dismiss) − product identification; misrepresentation; Conte
  • In re Zyprexa Products Liability Litigation, 2009 WL 5216930 (E.D.N.Y. Dec. 21, 2009) warning causation under the learned intermediary rule
  • In re Diet Drugs Products Liability Litigation, 1998 WL 254976 (E.D. Pa. April 16, 1998) (motion to remand) – pharmacy liability

Mississippi law cases
  • In re Darvocet, Darvon & Propoxyphene Products Liability Litigation, 2013 WL 663575 (E.D. Ky. Feb. 22, 2013) (motion to dismiss) − product identification; misrepresentation; Conte
  • In re Darvocet, Darvon & Propoxyphene Products Liability Litigation, 856 F. Supp.2d 904 (E.D. Ky. 2012) (motion to dismiss) − product identification; misrepresentation; Conte
  • In re Zyprexa Products Liability Litigation, 2011 WL 182489 (E.D.N.Y. Jan. 20, 2011) warning causation under the learned intermediary rule
  • In re Zyprexa Products Liability Litigation, 671 F. Supp.2d 397 (E.D.N.Y. 2009) consumer fraud; fraud; unjust enrichment; reliance; learned intermediary rule; fraud on the market; causation; economic loss rule
  • In re Fosamax Products Liability Litigation, 2009 WL 4042769 (S.D.N.Y. Nov. 23, 2009) warning causation under the learned intermediary rule
  • Ruth v. A.O. Smith Corp., 2005 WL 2978694 (N.D. Ohio Oct. 11, 2005) conspiracy; fraudulent omission
  • In re Rezulin Products Liability Litigation, 331 F. Supp.2d 196 (S.D.N.Y. 2004) adequacy as a matter of law
  • In re Diet Drugs Products Liability Litigation, 2004 WL 1535806 (E.D. Pa. June 18, 2004) (motion to remand) − sales representatives; pharmacy liability
  • In re Diet Drugs Products Liability Litigation, 2004 WL 1118714 (E.D. Pa. May 18, 2004) (motion to remand) − sales representatives
  • In re Diet Drugs Products Liability Litigation, 2004 WL 1102766 (E.D. Pa. May 17, 2004) (motion to remand) − pharmacy liability
  • In re Diet Drugs Products Liability Litigation, 2004 WL 1119925 (E.D. Pa. May 17, 2004) (motion to remand) − sales representatives
  • In re Diet Drugs Products Liability Litigation, 2004 WL 1125913 (E.D. Pa. May 14, 2004) (motion to remand) − sales representatives
  • In re Diet Drugs Products Liability Litigation, 2004 WL 966263 (E.D. Pa. May 4, 2004) (motion to remand) − pharmacy liability
  • In re Diet Drugs Products Liability Litigation, 2004 WL 1091054 (E.D. Pa. May 4, 2004) (motion to remand) − pharmacy liability
  • In re Diet Drugs Products Liability Litigation, 2004 WL 1504293 (E.D. Pa. Feb. 18, 2004) (motion to remand) – statute of limitations; fraudulent concealment
  • In re Rezulin Products Liability Litigation, 2003 WL 21396744 (S.D.N.Y. June 17, 2003) (motion to remand) − sales representatives; pharmacy liability
  • In re Rezulin Products Liability Litigation, 2003 WL 1900870 (S.D.N.Y. April 16, 2003) (motion to dismiss) − pharmacy liability
  • In re Rezulin Products Liability Litigation, 2003 WL 1900872 (S.D.N.Y. April 15, 2003) cognizable injury
  • In re Diet Drugs Products Liability Litigation, 220 F. Supp.2d 414 (E.D. Pa. 2002) (motion to remand) − sales representatives; pharmacy liability
  • In re Rezulin Products Liability Litigation, 2002 WL 31852826 (S.D.N.Y. Dec. 18, 2002) (motion to dismiss) – physician liability
  • In re Rezulin Products Liability Litigation, 133 F. Supp.2d 272 (S.D.N.Y. 2001) (motion to remand) − sales representatives; pharmacy liability

Missouri law cases
  • Carr-Davis v. Bristol-Myers Squibb Co., 2013 WL 322616 (D.N.J. Jan. 28, 2013) adequacy as a matter of law, efficacy as opposed to risk, warnings about risks not encountered by plaintiff, warning causation under the learned intermediary rule, heeding presumption, design defect, manufacturing defect, negligence, consumer fraud
  • In re Ford Motor Co. E-350 Van Products Liability Litigation (No. II), 2010 WL 2813788 (D.N.J. July 9, 2010) cognizable injury; warranty; statute of limitations; unjust enrichment
  • In re Zyprexa Products Liability Litigation, 2009 WL 1851062 (E.D.N.Y. June 22, 2009) warning causation under the learned intermediary rule
  • In re Saturn L-Series Timing Chain Products Liability Litigation, 2008 WL 4866604 (D. Neb. Nov. 7, 2008) unjust enrichment
  • In re Diet Drugs Products Liability Litigation, 2004 WL 2203712 (E.D. Pa. Sept. 28, 2004) (motion to remand) – sales representatives
  • In re Diet Drugs Products Liability Litigation, 2004 WL 220861 (E.D. Pa. Jan. 12, 2004) (motion to remand) – fraudulent concealment

Montana law cases
  • None

Nebraska law cases
  • None

Nevada law cases
  • In re Mirapex Products Liability Litigation, 2011 WL 3020268 (D. Minn. June 6, 2011) statute of limitations
  • In re Rezulin Products Liability Litigation, 2003 WL 25736933 (S.D.N.Y. April 9, 2003) (motion to remand) − pharmacy liability

New Hampshire law cases
  • In re Darvocet, Darvon & Propoxyphene Products Liability Litigation, 2012 WL 3842045 (E.D. Ky. Sept 5, 2012) product identification; misrepresentation; Conte

New Jersey law cases
  • Meridia Products Liability Litigation v. Abbott Laboratories, 447 F.3d 861 (6th Cir. 2006) warning adequacy as a matter of law
  • In re Zimmer NexGen Knee Implant Products Liability Litigation, 890 F. Supp.2d 896 (N.D. Ill. 2012) informal interviews with treating physicians
  • In re Darvocet, Darvon & Propoxyphene Products Liability Litigation, 856 F. Supp.2d 904 (E.D. Ky. 2012) (motion to dismiss) − product identification; misrepresentation; Conte
  • In re Zyprexa Products Liability Litigation, 2011 WL 4962184 (E.D.N.Y. Oct. 18, 2011) statute of limitations
  • In re Avandia Marketing, Sales Practices & Products Liability Litigation, 2011 WL 4007878 (E.D. Pa. Sept. 7, 2011) consumer fraud; unjust enrichment
  • In re Whirlpool Corp. Front-Loading Washer Products Liability Litigation, 684 F. Supp.2d 942 (N.D. Ohio 2009) unjust enrichment
  • In re Rezulin Products Liability Litigation, 392 F. Supp.2d 597 (S.D.N.Y. 2005) consumer fraud; standing; unjust enrichment
  • In re Rezulin Products Liability Litigation, 390 F. Supp.2d 319 (S.D.N.Y. 2005) consumer fraud; standing; unjust enrichment

New Mexico law cases
  • In re Trasylol Products Liability Litigation, 2011 WL 2586218 (S.D. Fla. June 23, 2011) warning causation under the learned intermediary rule
  • In re Rezulin Products Liability Litigation, 2003 WL 367117 (S.D.N.Y. Feb. 20, 2003) negligent infliction of emotional distress

New York law cases
  • In re MI Windows & Doors, Inc. Products Liability Litigation, 2013 WL 1363845 (D.S.C. April 3, 2013) (motion to dismiss) − consumer fraud; economic loss rule; express warranty; unjust enrichment
  • In re Mentor Corp. ObTape Transobturator Sling Products Liability Litigation, 2013 WL 123079 (M.D. Ga. Jan. 9, 2013) statute of limitations
  • In re Darvocet, Darvon & Propoxyphene Products Liability Litigation, 856 F. Supp.2d 904 (E.D. Ky. 2012) (motion to dismiss) − product identification; misrepresentation; Conte
  • In re Accutane Products Liability Litigation, 2012 WL 3194954 (M.D. Fla. July 24, 2012) adequacy as a matter of law
  • In re Avandia Marketing, Sales Practices & Products Liability Litigation, 2011 WL 4007886 (E.D. Pa. Sept. 7, 2011) consumer fraud; unjust enrichment
  • In re Whirlpool Corp. Front-Loading Washer Products Liability Litigation, 684 F. Supp.2d 942 (N.D. Ohio 2009) warranty; privity
  • In re Avandia Marketing, Sales Practices & Products Liability Litigation, 624 F. Supp.2d 396 (E.D. Pa. 2009) (motion to remand) − pharmacy liability
  • In re Bridgestone/Firestone, Inc., Tires Products Liability Litigation, 287 F. Supp.2d 936 (S.D. Ind. 2003) failure to prove defect where product lost
  • In re Ford Motor Co. Bronco II Products Liability Litigation, 1995 WL 714441, (E.D. La. Dec. 4, 1995) (motion to dismiss) − economic loss rule

North Carolina law cases
  • In re Zyprexa Products Liability Litigation, 2011 WL 4962349 (E.D.N.Y. Oct. 18, 2011) warning causation under the learned intermediary rule
  • In re Zyprexa Products Liability Litigation, 2010 WL 4052913 (E.D.N.Y. Oct. 14, 2010) warning causation under the learned intermediary rule
  • In re Whirlpool Corp. Front-Loading Washer Products Liability Litigation, 684 F. Supp.2d 942 (N.D. Ohio 2009) warranty; privity
  • In re StarLink Corn Products Liability Litigation, 212 F. Supp.2d 828 (N.D. Ill. 2002) (motion to dismiss) − consumer fraud; extraterritoriality
  • In re TMJ Implants Products Liability Litigation, 872 F. Supp. 1019 (D. Minn. 1995) (motion to dismiss) – physician strict liability; emotional distress

North Dakota law cases
  • None

Ohio law cases
  • In re MI Windows & Doors, Inc. Products Liability Litigation, 2012 WL 4482928 (D.S.C. 2012) unjust enrichment, fraudulent concealment, consumer fraud
  • In re Porsche Cars North America, Inc., 880 F. Supp.2d 801 (S.D. Ohio 2012) implied warranty
  • In re Darvocet, Darvon & Propoxyphene Products Liability Litigation, 856 F. Supp.2d 904 (E.D. Ky. 2012) (motion to dismiss) − product identification; misrepresentation; Conte
  • In re Zyprexa Products Liability Litigation, 2011 WL 5563524 (E.D.N.Y. Nov. 15, 2011) statute of limitations
  • In re Bextra & Celebrex Marketing Sales Practices & Product Liability Litigation, 495 F. Supp.2d 1027 (N.D. Cal. 2007) (motion to dismiss) − consumer fraud; standing
  • In re TMJ Implants Products Liability Litigation, 872 F. Supp. 1019 (D. Minn. 1995), aff’d, 97 F.3d 1050 (8th Cir. 1996) sophisticated user; bulk purchaser

Oklahoma law cases
  • In re Trasylol Products Liability Litigation, 2013 WL 1080552 (S.D. Fla. March 14, 2013) causation; warning causation under the learned intermediary rule
  • In re Darvocet, Darvon & Propoxyphene Products Liability Litigation, 856 F. Supp.2d 904 (E.D. Ky. 2012) (motion to dismiss) − product identification; misrepresentation; Conte
  • In re Darvocet, Darvon & Propoxyphene Products Liability Litigation, 2012 WL 3984871 (E.D. Ky. Sept. 10, 2012) (motion to dismiss) − product identification; misrepresentation; Conte
  • In re Zyprexa Products Liability Litigation, 2011 WL 2516333 (E.D.N.Y. June 23, 2011) warning causation under the learned intermediary rule
  • In re Trasylol Products Liability Litigation, 2011 WL 1033650 (S.D. Fla. Jan. 18, 2011) statute of limitations; fraud; reliance; consumer fraud; standing

Oregon law cases
  • In re Zyprexa Products Liability Litigation, 727 F. Supp.2d 101 (E.D.N.Y. 2010) statute of limitations
  • In re TMJ Implants Products Liability Litigation, 872 F. Supp. 1019 (D. Minn. 1995), aff’d, 97 F.3d 1050 (8th Cir. 1996) sophisticated user; bulk purchaser

Pennsylvania law cases
  • In re Darvocet, Darvon & Propoxyphene Products Liability Litigation, 856 F. Supp.2d 904 (E.D. Ky. 2012) (motion to dismiss) − product identification; misrepresentation; Conte
  • In re Zyprexa Products Liability Litigation, 2012 WL 252838 (E.D.N.Y. Jan. 26, 2012) warning causation under the learned intermediary rule
  • In re Yasmin & Yaz Marketing, Sales Practices & Products Liability Litigation, 2010 WL 3119499 (S.D. Ill. Aug. 5, 2010) (motion to dismiss) – proximate cause; unjust enrichment
  • In re Zyprexa Products Liability Litigation, 2009 WL 1404978 (E.D.N.Y. May 19, 2009), aff’d, 396 Fed. Appx. 715 (2d Cir. 2010) warning causation under the learned intermediary rule
  • In re Zyprexa Products Liability Litigation, 2009 WL 1514427 (E.D.N.Y. May 29, 2009) warning causation under the learned intermediary rule
  • In re Vioxx Products Liability Litigation, 522 F. Supp.2d 799 (E.D. La. 2007) statute of limitations; cross-jurisdictional class action tolling
  • In re Zyprexa Products Liability Litigation, 489 F. Supp.2d 230 (E.D.N.Y. 2007) statute of limitations

Puerto Rico law cases
  • In re Vioxx Products Liability Litigation, 522 F. Supp.2d 799 (E.D. La. 2007) statute of limitations; consumer fraud

Rhode Island law cases
  • In re Zyprexa Products Liability Litigation, 277 F.R.D. 243 (E.D.N.Y. 2011) warning causation under the learned intermediary rule

South Carolina law cases
  • In re Mentor Corp. ObTape Transobturator Sling Products Liability Litigation, 2013 WL 503074 (M.D. Ga. Feb. 11, 2013) statute of limitations
  • In re Darvocet, Darvon & Propoxyphene Products Liability Litigation, 856 F. Supp.2d 904 (E.D. Ky. 2012) (motion to dismiss) − product identification; misrepresentation; Conte
  • In re TMJ Implants Products Liability Litigation, 872 F. Supp. 1019 (D. Minn. 1995), aff’d, 97 F.3d 1050 (8th Cir. 1996) sophisticated user; bulk purchaser

South Dakota law cases
  • None

Tennessee law cases
  • In re Darvocet, Darvon & Propoxyphene Products Liability Litigation, 856 F. Supp.2d 904 (E.D. Ky. 2012) (motion to dismiss) − product identification; misrepresentation; Conte
  • In re Avandia Marketing, Sales Practices & Products Liability Litigation, 2012 WL 3205620 (E.D. Pa. Aug. 7, 2012) statute of limitations
  • In re Conagra Peanut Butter Products Liability Litigation, 2009 WL 3011220 (N.D. Ga. Sept. 15, 2009) (motion to dismiss) – corporate officer liability
  • In re Vioxx Products Liability Litigation, 2007 WL 3353404 (E.D. La. Nov. 8, 2007) statute of limitations, cross-jurisdictional class action tolling
  • In re TMJ Implants Products Liability Litigation, 872 F. Supp. 1019 (D. Minn. 1995), aff’d, 97 F.3d 1050 (8th Cir. 1996) sophisticated user; bulk purchaser

Texas law cases
  • Solomon v. Bristol-Myers Squibb Co., ___ F. Supp.2d ___, 2013 WL 64778 (D.N.J. Jan. 3, 2013) adequacy as a matter of law, warnings about risks not encountered by plaintiff, efficacy as opposed to risk, warning causation under the learned intermediary rule, statutory presumption of adequacy, design defect, manufacturing defect, negligence
  • In re Darvocet, Darvon & Propoxyphene Products Liability Litigation, 856 F. Supp.2d 904 (E.D. Ky. 2012) (motion to dismiss) − product identification; misrepresentation; Conte
  • In re Trasylol Products Liability Litigation, 2012 WL 1662151 (S.D. Fla. May 9, 2012) statute of limitations
  • In re Heparin Products Liability Litigation, 2011 WL 3843818 (N.D. Ohio Aug. 30, 2011) product identification
  • In re Trasylol Products Liability Litigation, 2011 WL 5417173 (S.D. Fla. Aug. 16, 2011) statute of limitations
  • In re Mirapex Products Liability Litigation, 735 F. Supp.2d 1113 (D. Minn. 2010) statute of limitations; discovery rule
  • In re Yamaha Motor Corp. Rhino ATV Products Liability Litigation, 2009 WL 939279 (W.D. Ky. April 6, 2009) intermediate seller
  • In re Bextra & Celebrex Marketing Sales Practices & Product Liability Litigation, 495 F. Supp.2d 1027 (N.D. Cal. 2007) (motion to dismiss) − consumer fraud; standing
  • In re Vioxx Products Liability Litigation, 2007 WL 3334339 (E.D. La. Nov. 8, 2007) statute of limitations, cross-jurisdictional class action tolling
  • In re Cessna 208 Series Aircraft Products Liability Litigation, 2006 WL 3858465 (D. Kan. Dec. 22, 2006) (motion to amend) – fraud
  • In re Rezulin Products Liability Litigation, 361 F. Supp.2d 268 (S.D.N.Y. 2005) compensable injury
  • In re Rezulin Products Liability Litigation, 331 F. Supp.2d 196 (S.D.N.Y. 2004) causation; warnings about condition plaintiff did not have; warning causation under the learned intermediary rule
  • In re Diet Drugs Products Liability Litigation, 2004 WL 1535828 (E.D. Pa. July 6, 2004) (motion to remand) − statute of limitations; pharmacy liability; sales representatives
  • In re Rezulin Products Liability Litigation, 133 F. Supp.2d 272 (S.D.N.Y. 2001) (motion to remand) − pharmacy liability
  • In re Air Bag Products Liability Litigation, 7 F. Supp.2d 792 (E.D. La. 1998) economic loss rule; implied warranty; cognizable injury
  • In re TMJ Implants Products Liability Litigation, 872 F. Supp. 1019 (D. Minn. 1995), aff’d, 97 F.3d 1050 (8th Cir. 1996) sophisticated user; bulk purchaser

Utah law cases
  • In re Zimmer NexGen Knee Implant Products Liability Litigation, 890 F. Supp.2d 896 (N.D. Ill. 2012) (discovery motion) − informal interview with treating physician
  • In re Cessna 208 Series Aircraft Products Liability Litigation, 2006 WL 3858465 (D. Kan. Dec. 22, 2006) (motion to amend) − fraud

Vermont law cases
  • None

Virginia law cases
  • In re Zyprexa Products Liability Litigation, 2011 WL 4357319 (E.D.N.Y. Sept. 16, 2011) statute of limitations
  • In re Trasylol Products Liability Litigation, 2011 WL 2784237 (S.D. Fla. July 13, 2011) (judgment on the pleadings) − statute of limitations
  • In re Fosamax Products Liability Litigation, 694 F. Supp.2d 253 (S.D.N.Y. 2010), aff’d after certification, 678 F.3d 134 (2d Cir. 2012) cross-jurisdictional class action tolling
  • In re Trasylol Products Liability Litigation, 2010 WL 5151579 (S.D. Fla. Nov. 16, 2010) statute of limitations; consumer fraud
  • In re Zyprexa Products Liability Litigation, 2009 WL 2487305 (E.D.N.Y. July 27, 2009) warning causation under the learned intermediary rule
  • In re Phenylpropanolamine (PPA) Products Liability Litigation, 2005 WL 1126925 (W.D. Wash. May 11, 2005) statute of limitations; fraudulent concealment
  • In re Rezulin Products Liability Litigation, 2002 WL 31548715 (S.D.N.Y. Nov. 15, 2002) (motion to remand) – sales representatives
  • In re TMJ Implants Products Liability Litigation, 872 F. Supp. 1019 (D. Minn. 1995), aff’d, 97 F.3d 1050 (8th Cir. 1996) sophisticated user; bulk purchaser

Washington law cases
  • In re Yazmin & Yaz Marketing, Sales Practices and Products Liability Litigation, 2011 WL 3796903 (S.D. Ill. 2011 Aug. 25, 2011) (motion to remand) − physicians and hospitals
  • In re TMJ Implants Products Liability Litigation, 872 F. Supp. 1019 (D. Minn. 1995), aff’d, 97 F.3d 1050 (8th Cir. 1996) sophisticated user; bulk purchaser

West Virginia law cases
  • In re Imprelis Herbicide Marketing, Sales Practices & Products Liability Litigation, 2013 WL 363693 (E.D. Pa. Jan. 30, 2013) (motion to remand) – negligent referral
  • In re Zyprexa Products Liability Litigation, 2009 WL 1514628 (E.D.N.Y. June 1, 2009) warning causation
  • In re Rezulin Products Liability Litigation, 133 F. Supp.2d 272 (S.D.N.Y. 2001) (motion to remand) − pharmacy liability
  • In re TMJ Implants Products Liability Litigation, 872 F. Supp. 1019 (D. Minn. 1995), aff’d, 97 F.3d 1050 (8th Cir. 1996) sophisticated user; bulk purchaser

Wisconsin law cases
  • In re TMJ Implants Products Liability Litigation, 872 F. Supp. 1019 (D. Minn. 1995), aff’d, 97 F.3d 1050 (8th Cir. 1996) sophisticated user; bulk purchaser

Wyoming law cases
  • None

1 comment:

Anonymous said...

"Yeah, we saw some bad cases while doing this research. We’ve intentionally omitted them."

Just like every defendant brief I've ever seen does